profit from every $100 of sales.
$0$100
Afya
$10.73+2.09% today
-25.6% in 1 year
1-year low $10.151-year high $15.86
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $7.04 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Afya sold, what it kept, and what it did with the cash.
Sales went from R$2.33 billion in 2022 to R$3.70 billion in 2025, with R$752 million of profit last year.
SalesProfit
Afya vs. similar companies
Afya grows the fastest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Afya | 7.0× · Cheap | ||
 New Oriental Education & Technology Group | 22.0× · Fair price | ||
 TAL Education Group | 66.0× · Very expensive | ||
 Graham | 17.4× · Fair price | ||
 Laureate Education | 17.2× · Fair price |
AI analysis
An AI analyst reads Afya's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,329 | 2,876 | 3,304 | 3,697 | |
| 1,470 | 1,766 | 2,089 | 2,383 | |
| 664 | 767 | 1,012 | 1,213 | |
| 923 | 1,105 | 1,376 | 1,674 | |
| 374 | 386 | 632 | 752 | |
| 4.12 | 4.27 | 6.93 | 8.24 | |
| 63.1% | 61.4% | 63.2% | 64.5% | |
| 28.5% | 26.7% | 30.6% | 32.8% | |
| 16.0% | 13.4% | 19.1% | 20.4% |
Balance sheet
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 7,200 | 7,584 | 8,830 | 9,358 |
| Cash | 1,093 | 553 | 911 | 1,125 |
| Total debt | 2,715 | 2,675 | 3,173 | 3,120 |
| Total liabilities | 3,949 | 3,941 | 4,519 | 4,467 |
| 3,199 | 3,602 | 4,270 | 4,852 | |
| 90 | 91 | 91 | 91 | |
| 9.6% | 10.3% | 11.1% | 12.9% | |
| 11.7% | 10.7% | 14.8% | 15.5% |
Cash flow
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 844 | 1,044 | 1,433 | 1,532 | |
| 297 | 245 | 393 | 364 | |
| 547 | 798 | 1,040 | 1,168 | |
| Dividends paid | 0 | 0 | 0 | 0 |
| 152 | 12 | – | – | |
| 31 | 32 | 32 | 15 |
Valuation
- 7.0×
- 1.1×
- 0.27
- 1.0×
- 1.4×
- 4.5×
- 4.4×
- 22.0%
- 14.2%
- 0.0%
Profitability
- 64.5%
- 32.8%
- 20.4%
- 41.8%
- 13.2%
- 11.2%
- 16.0%
- 7.9%
- 14.8%
- –
Growth
- +16.7%
- +26.0%
- −0.3%
- –
- +0.5%
Financial health
- 1.2×
- 0.64
- 33.3%
- 3.0×
- 2.20
- 1.78
- 0.40
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 30%of 670
Top 4%of 674
Top 6%of 624
Top 13%of 673
Top 5%of 668
What analysts expect
- Average price target
- $16.33
- Range
- $16.00 – $17.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 0.56 | 0.53 | +5.7% |
| Mar 12, 2026 | 0.41 | 0.38 | +7.9% |
| Nov 12, 2025 | 0.38 | 0.32 | +18.8% |
| Aug 13, 2025 | 0.40 | 0.40 | +0.0% |
| May 8, 2025 | 0.55 | 0.46 | +19.6% |
| Mar 13, 2025 | 0.36 | 0.34 | +5.9% |
| Nov 13, 2024 | 0.32 | 0.36 | −11.1% |
| Aug 15, 2024 | 0.44 | 0.37 | +18.9% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
7/7Passes 7 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
80Pass
Benjamin Graham
93Pass
Philip Fisher
94Pass
Peter Lynch
95Pass
Joel Greenblatt
71Pass
Charlie Munger
72Pass
Terry Smith
72Pass
Questions about Afya
Is Afya a good stock to buy?
A strong, very profitable business, and the price looks low. 7 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Afya AI analysis
What does Afya do?
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. It is in Education & Training Services.
Does Afya pay a dividend?
No. Afya does not pay a dividend at the moment.
Is Afya stock halal?
No. Afya does not pass our halal screen: its debt is 59% of its market value, at or above the 33% limit. How we check
How has Afya stock done over the past year?
Down 25.6% over the past twelve months, to $10.73. It traded between $10.15 and $15.86 and is 32.3% below its high.
Who are Afya's competitors?
The largest listed companies in the same industry are New Oriental Education & Technology Group, TAL Education Group, Graham and Laureate Education. The peers table on this page compares their profit, growth and price with Afya's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.